236 related articles for article (PubMed ID: 21645349)
1. Transport processes of radiopharmaceuticals and -modulators.
Efferth T; Langguth P
Radiat Oncol; 2011 Jun; 6():59. PubMed ID: 21645349
[TBL] [Abstract][Full Text] [Related]
2. The effect of P-glycoprotein function inhibition with cyclosporine A on the biodistribution of Tc-99m sestamibi.
Kabasakal L; Halaĉ M; Nisli C; Oguz O; Onsel C; Civi G; Uslu I
Clin Nucl Med; 2000 Jan; 25(1):20-3. PubMed ID: 10634525
[TBL] [Abstract][Full Text] [Related]
3. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the in vitro and in vivo properties of a (99m)Tc-labeled inhibitor of the multidrug resistant gene product P-glycoprotein.
Bergmann R; Brust P; Scheunemann M; Pietzsch HJ; Seifert S; Roux F; Johannsen B
Nucl Med Biol; 2000 Feb; 27(2):135-41. PubMed ID: 10773542
[TBL] [Abstract][Full Text] [Related]
5. Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m MIBI parathyroid image findings.
Sun SS; Shiau YC; Lin CC; Kao A; Lee CC
Nucl Med Biol; 2001 Nov; 28(8):929-33. PubMed ID: 11711312
[TBL] [Abstract][Full Text] [Related]
6. Effect of P-glycoprotein and multidrug resistance associated protein gene expression on Tc-99m MIBI imaging in hepatocellular carcinoma.
Chang CS; Huang WT; Yang SS; Yeh HZ; Kao CH; Chen GH
Nucl Med Biol; 2003 Feb; 30(2):111-7. PubMed ID: 12623109
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line.
Utsunomiya K; Ballinger JR; Piquette-Miller M; Rauth AM; Tang W; Su ZF; Ichise M
Eur J Nucl Med; 2000 Dec; 27(12):1786-92. PubMed ID: 11189941
[TBL] [Abstract][Full Text] [Related]
8. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin.
Gomes CM; Abrunhosa AJ; Pauwels EK; Botelho MF
Cancer Biother Radiopharm; 2009 Apr; 24(2):215-27. PubMed ID: 19409044
[TBL] [Abstract][Full Text] [Related]
10. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM
Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962
[TBL] [Abstract][Full Text] [Related]
11. Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Cancer Lett; 2000 May; 153(1-2):95-100. PubMed ID: 10779636
[TBL] [Abstract][Full Text] [Related]
12. A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors.
Kelly RJ; Robey RW; Chen CC; Draper D; Luchenko V; Barnett D; Oldham RK; Caluag Z; Frye AR; Steinberg SM; Fojo T; Bates SE
Oncologist; 2012; 17(4):512. PubMed ID: 22416063
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m sestamibi imaging as an indicator of P-glycoprotein expression in metastatic pheochromocytoma.
Derebek E; Capa G; Berk H; Sekeroğlu B; Havitçioğlu H; Değirmenci B; Alakavuklar M; Durak H
Clin Nucl Med; 1998 Sep; 23(9):637-8. PubMed ID: 9736000
[No Abstract] [Full Text] [Related]
14. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
[TBL] [Abstract][Full Text] [Related]
15. Carbon-11 labeled tracers for in vivo imaging P-glycoprotein function: kinetics, advantages and disadvantages.
Luurtsema G; Verbeek GL; Lubberink M; Lammertsma AA; Dierckx R; Elsinga P; Windhorst AD; van Waarde A
Curr Top Med Chem; 2010; 10(17):1820-33. PubMed ID: 20645915
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary elimination rate of inhaled 99mTc-sestamibi radioaerosol is delayed in healthy cigarette smokers.
Ruparelia P; Cheow HK; Evans JW; Banney L; Shankar S; Szczepura KR; Swift AE; Ballinger JR; Hartman NG; Chilvers ER; Peters AM
Br J Clin Pharmacol; 2008 Apr; 65(4):611-4. PubMed ID: 18279466
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of technetium 99m sestamibi parathyroid imaging and the possible role of p-glycoprotein.
Mitchell BK; Cornelius EA; Zoghbi S; Murren JR; Ghoussoub R; Flynn SD; Kinder BK
Surgery; 1996 Dec; 120(6):1039-45. PubMed ID: 8957492
[TBL] [Abstract][Full Text] [Related]
18. Avoiding barriers to PET radioligand development: cellular assays of brain efflux transporters.
Hall MD; Pike VW
J Nucl Med; 2011 Mar; 52(3):338-40. PubMed ID: 21321273
[No Abstract] [Full Text] [Related]
19. Noninvasive functional imaging of P-glycoprotein-mediated doxorubicin resistance in a mouse model of hereditary breast cancer to predict response, and assign P-gp inhibitor sensitivity.
van Leeuwen FW; Buckle T; Kersbergen A; Rottenberg S; Gilhuijs KG
Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):406-12. PubMed ID: 19093112
[TBL] [Abstract][Full Text] [Related]
20. Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients.
Takamura Y; Miyoshi Y; Taguchi T; Noguchi S
Cancer; 2001 Jul; 92(2):232-9. PubMed ID: 11466674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
